Prime‐boost vaccination strategy with bacillus Calmette–Guérin (BCG) and liposomized alpha‐crystalline protein 1 reinvigorates BCG potency

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|2|286-296

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.2, 2015-08, pp. : 286-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone marrow infection with bacillus Calmette-Guérin (BCG) after intravesical immunotherapy

By Nemeth Johannes  

Wiener klinische Wochenschrift, Vol. 120, Iss. 3-4, 2008-02 ,pp. : 121-123

Springer Publishing Company

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

Toll‐like receptor 2 subfamily gene polymorphisms are associated with Bacillus Calmette‐Guérin osteitis following newborn vaccination

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 5, 2015-05 ,pp. : 485-490

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoimmune Clinical Manifestations following Intravesical Bacillus Calmette-Guérin and Interferon alpha 2b Immunotherapy for Superficial Bladder Cancer

By  

Current Urology, Vol. 3, Iss. 1, 2009-05 ,pp. : 36-40

Karger

Access to resources Recommend Favorite

Recurrence and Progression of T1G3 Transitional Cell Carcinoma of the Bladder Treated with Intravesical Bacillus Calmette-Guérin

By  

Urologia Internationalis, Vol. 75, Iss. 2, 2008-07 ,pp. : 107-113

Karger

Access to resources Recommend Favorite